| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Pharmacology and Cell Biophysics, University of Cincinnati, Cincinnati, Ohio, USA
2 Department of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, Ohio, USA
3 Division of Cardiology, Department of Medicine, University of Cincinnati, Cincinnati, Ohio, USA
4 Department of Medicine, Jefferson Medical College, Philadelphia, PA, USA
* To whom correspondence should be addressed. E-mail: joneswk{at}uc.edu.
The role of NF-
B in cardiac physiology and pathophysiology has been difficult to delineate due to the inability to specifically block NF-B signaling in the heart. Cardiac specific transgenic models have recently been developed that repress NF-B activation by preventing phosphorylation at specific serine residues of IB
. However, these models are unable to completely block NF-B because of a second signaling pathway that regulates NF-B function via Tyr42 phosphorylation of IB. We report the development of transgenic (3M) mouse lines that express a mutant IBS32A,S36A,Y42F in a cardiac specific manner. NF-B activation in cardiomyopathic TNF1.6 mice is completely blocked by the 3M transgene, but only partially blocked (70-80%) by the previously described double mutant 2M (IBS32A,S36A) transgene, demonstrating the action of two proximal pathways for NF-B activation in TNF--induced cardiomyopathy. In contrast, after acute stimuli, including administration of TNF- and ischemia/reperfusion in vivo, NF-B activation is blocked in both the 2M and 3M transgenic mice. This result suggests that phosphorylation of the regulatory Ser32,36 predominantly mediates NF-B activation in these situations. We show that infarct size after I/R is reduced by 70% in 3M transgenic mice, conclusively demonstrating that NF-B is involved in I/R injury. In summary, we have engineered novel transgenic mice that allow us to distinguish two major proximal pathways for NF-B activation. Our results demonstrate that the serine and tyrosine phosphorylation pathways are differentially activated during different pathophysiological processes (cardiomyopathy and I/R injury) and that NF-B contributes to infarct development after I/R.
This article has been cited by other articles:
|
|
 |
|
  L. Timmers, J. K. van Keulen, I. E. Hoefer, M. F.L. Meijs, B. van Middelaar, K. den Ouden, C. J.A. van Echteld, G. Pasterkamp, and D. P.V. de Kleijn Targeted Deletion of Nuclear Factor {kappa}B p50 Enhances Cardiac Remodeling and Dysfunction Following Myocardial Infarction Circ. Res., March 13, 2009; 104(5): 699 - 706. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Frantz, J. Bauersachs, and G. Ertl Post-infarct remodelling: contribution of wound healing and inflammation Cardiovasc Res, February 15, 2009; 81(3): 474 - 481. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Yang, J. Wu, C. M. Martin, P. R. Kvietys, and T. Rui Important role of p38 MAP kinase/NF-{kappa}B signaling pathway in the sepsis-induced conversion of cardiac myocytes to a proinflammatory phenotype Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H994 - H1001. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kawano, T. Kubota, Y. Monden, T. Tsutsumi, T. Inoue, N. Kawamura, H. Tsutsui, and K. Sunagawa Blockade of NF-{kappa}B improves cardiac function and survival after myocardial infarction Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1337 - H1344. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Higuchi, T. O. Chan, M. A. Brown, J. Zhang, B. R. DeGeorge Jr., H. Funakoshi, G. Gibson, C. F. McTiernan, T. Kubota, W. K. Jones, et al. Cardioprotection afforded by NF-{kappa}B ablation is associated with activation of Akt in mice overexpressing TNF-{alpha} Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H590 - H598. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
